Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can ancient ayurveda help cancer survivors? new study tests feasibility

NCT ID NCT06633926

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study looks at whether two different health programs are practical and acceptable for women who have finished treatment for early-stage breast cancer. One program combines nutrition advice, lifestyle changes, yoga, and therapeutic touch (Ayurveda). The other is a self-guided online health education program. The goal is to see if survivors will join, stay in, and complete these programs, not to measure health outcomes. About 106 participants will be randomly assigned to one of the two programs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ayurveda intervention (nutrition education, lifestyle counseling, yoga, therapeutic touch) and health education program
What this could lead to
If successful, this could show that integrative approaches like Ayurveda are practical and acceptable for cancer survivors, paving the way for larger studies on their benefits.
What could go wrong
This is a small, early feasibility study, not designed to test if the interventions actually improve health. Results may not apply to all survivors, and participants might not find the programs acceptable or easy to follow.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

107 people

The number who actually took part.

Started

Mar 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients 1. Age \>= 18 2. Able to understand study procedures and to comply with them for the entire length of the study. 3. Able to read, write, and understand English. 4. Ability of individual or legal guardian/representative to understand a verbal informed consent document, and the willingness to sign it. 5. Non-metastatic breast cancer patients who are between 1 and 36 months after completion of primary treatment (i.e., surgery, radiotherapy, chemotherapy) and are in a complete remission. 6. Participants should have received chemotherapy as part of their primary treatment. 7. Have an impaired quality of life (report a score of 5 or less on question 30 of the European Organisation for Research and Treatment of Cancer Quality of Life Cancer questionnaire (EORTC-QLQ-C30). "How would you rate your overall quality of life during the past week?" 8. Karnofsky Performance Status Score (KPS) \>=60 Ayurveda Practitioners 1\. Must be engaged as an Ayurvedic Intervention practitioner on the Renew study Exclusion Criteria: Patients 1. Contraindication to any study-related procedure or assessment. 2. Metastatic disease and receiving chemotherapy or radiotherapy at the time of study enrollment (participants with non-metastatic disease who are receiving anti-Her2 directed treatment alone in the adjuvant setting are eligible). 3. Participants are within 1 month after surgery for cancer, including breast reconstructive surgery but not including implant exchange. 4. Cancer surgery planned during the initial 6-month study period. 5. Been on adjuvant hormone therapy (for breast cancer) less than 2 months at the time of enrollment. 6. Received Ayurvedic treatment during the 3 months preceding enrollment. 7. If a participant reports severe anxiety or depression, has severe depression assessed by Patient Health Questionnaire (PHQ)-9 using a cut-off of 20 or higher, or severe anxiety assessed by the General Anxiety Disorder-7 (GAD-7) using a cut-off 15 or higher. 8. Current suicidal ideation. Ayurveda Practitioners 1\. None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anatomic stage I breast cancer ajcc V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kaiser Permanente Northwest (KPNW)

    San Francisco, California, 94158, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

  • Vanderbilt Ingram Cancer Center

    Nashville, Tennessee, 37212, United States

  • Zuckerberg San Francisco General

    San Francisco, California, 94115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.